Treosulfan as an Effective Second-Line Therapy in Ovarian Cancer
- 1 October 1998
- journal article
- clinical trial
- Published by Elsevier in Gynecologic Oncology
- Vol. 71 (1) , 94-98
- https://doi.org/10.1006/gyno.1998.5103
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Living with Ovarian CancerGynecologic Oncology, 1993
- Entwicklungen in der Therapie des fortgeschrittenen Ovarialkarzinoms FIGO IIIGeburtshilfe und Frauenheilkunde, 1993
- Secondary cytoreduction for ovarian cancer following cisplatin therapy.Journal of Clinical Oncology, 1993
- Stellenwert der Rezidivchirurgie in der Behandlung des OvarialkarzinomsGeburtshilfe und Frauenheilkunde, 1993
- Hexamethylmelamine as second-line therapy in platin-resistant ovarian cancerGynecologic Oncology, 1992
- Radical surgical procedure improves survival time in patients with recurrent ovarian cancerCancer, 1992
- Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin.Journal of Clinical Oncology, 1991
- Crossover study with cisplatin or carboplatin in advanced ovarian cancerGynecologic Oncology, 1990
- Cisplatin/carboplatin cross-resistance in ovarian cancerBritish Journal of Cancer, 1989
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958